Quick Answer
Hypha Labs, Inc. reported Diluted EPS of $0.02 per share (loss) for fiscal year 2025.
Hypha Labs, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.02 | -100.0% |
| 2024 | -$0.01 | — |
| 2023 | $0.00 | +100.0% |
| 2022 | -$0.03 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.00 | +100.0% | — |
| June 30, 2025 | $0.00 | +100.0% | +100.0% |
| March 31, 2025 | -$0.01 | — | +0.0% |
| December 31, 2024 | -$0.01 | — | +0.0% |
| June 30, 2024 | -$0.01 | — | — |
| March 31, 2024 | $0.00 | — | — |
| December 31, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | +100.0% | — |
- Hypha Labs, Inc. showed a decrease of -100.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Hypha Labs, Inc.’s diluted eps has grown by 33.3% (from $0.03 per share (loss) to $0.02 per share (loss)).
- The most recent figure is from Hypha Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 15, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: